1.Comparison of the effects of acupuncture with Neiguan(PC6)-to-Waiguan(TE5) and esmolol on hemodynamics during anesthesia induction and postoperative nausea and vomiting.
Jiping XU ; Jiafu JI ; Lan ZHAO ; Yuanyuan ZHAO ; Fan SU
Chinese Acupuncture & Moxibustion 2025;45(9):1265-1270
OBJECTIVE:
To compare the clinical efficacy of acupuncture with Neiguan (PC6)-to-Waiguan (TE5) and esmolol on hemodynamics during anesthesia induction and postoperative nausea and vomiting.
METHODS:
A total of 100 patients undergoing elective laparoscopic hernia repair or gynecological surgery under general anesthesia were randomly divided into an acupuncture group (50 cases, 3 cases were eliminated) and an esmolol group (50 cases, 2 cases were eliminated). In the acupuncture group, before anesthesia induction, patients were applied to acupuncture with Neiguan (PC6)-to-Waiguan (TE5), and the needles were retained for 15 min on the right side and 30 min on the left side. Patients in the esmolol group were intravenously injected with 20 mg esmolol hydrochloride injection 5 min before anesthesia induction. The systolic blood pressure (SBP) and heart rate (HR) of the two groups were recorded at 5 min after entering the operating room (T0), before anesthesia induction (T1), after anesthesia induction (T2), before tracheal intubation (T3) and 1 min after tracheal intubation (T4). The visual analogue scale (VAS) scores of pain and the incidence of nausea and vomiting in the two groups were observed at the time of entering postanesthesia care unit (PACU) (T5), leaving PACU (T6), 6 h after operation (T7) and 24 h after operation (T8). The dosage of anesthesia-related drugs in the two groups was counted.
RESULTS:
The SBP and HR of the two groups at T2, T3 and T4 were lower than those at T1 (P<0.05). SBP and HR at T3 in the acupuncture group were higher than those in the esmolol group (P<0.05). Compared with the esmolol group, in the acupuncture group, the VAS scores of pain at T6 and T7 were decreased (P<0.05), the incidence of nausea and vomiting at T7 and T8 and the nausea and vomiting visual analogue scale (NVAS) scores were decreased (P<0.05). Compared with the esmolol group, the dosage of propofol in the acupuncture group was decreased (P<0.05).
CONCLUSION
Acupuncture with Neiguan (PC6)-to-Waiguan (TE5) can relieve hemodynamic fluctuations during anesthesia induction, reduce postoperative pain and nausea and vomiting, and reduce the dosage of propofol. The curative effect is better than that of esmolol.
Humans
;
Female
;
Adult
;
Middle Aged
;
Acupuncture Points
;
Male
;
Hemodynamics
;
Propanolamines/administration & dosage*
;
Postoperative Nausea and Vomiting/drug therapy*
;
Young Adult
;
Heart Rate
;
Aged
;
Blood Pressure
;
Acupuncture Therapy
2.Education and certification model for radiation dosimetrists in the United States: Implications and reference for China
Wenjie WU ; Junliang XU ; Guoping SHAN ; Binbing WANG ; Feng LU ; Xue BAI ; Xiaolong CHENG ; Dannong RUAN ; Jiping LIU
Chinese Journal of Radiological Medicine and Protection 2025;45(1):69-73
Given the escalating number of cancer patients and the consequent rise in demand for radiation therapy in China, there is an urgent need to establish and improve a talent cultivation system for radiation dosimetrists. The United States, with an early-established cultivation system for radiation dosimetrists, boasts relatively mature and comprehensive systems of academic education and qualification certification. This study summarized and analyzed the educational and certification patterns for radiation dosimetrists in the United States based on public data from relevant institutions, related literature, and interviews with American radiation dosimetrists. Meanwhile, this study delved into and assessed the shortcomings in China′s radiation dosimetry education, examination, certification, and career advancement pathways. Furthermore, this study offered suggestions and recommendations for constructing a novel pattern tailored to the cultivation of radiation dosimetrists in China, in order to facilitate the high-quality development of the medical dosimetry discipline.
3.Construction of world-class naval health service system by developing high-quality naval hospitals
Chongyang OU ; Li SHUAI ; Tao DING ; Jiping XU ; Dong XIA ; Jun WANG
Journal of Navy Medicine 2025;46(4):343-346
Naval hospitals,the backbone of naval health service system,are the key to build a world-class naval health service system.On the basis of the requirements of military transformation and high-quality development of public hospitals,this paper summarized five aspects of high-quality development of naval hospitals,including directions and regulations,support and contribution of combats,efficiency,sustainable development momentum,and the expansion of service functions.It is very important to strengthen the top-level design and policy support for naval hospitals,to improve the level of governance and innovation,and to find the right target for the naval hospital construction in naval health service system reform.
4.Similarities and Differences of Source Plasma Collection and Quality Control In China and Abroad
Demei DONG ; Yang GAO ; Yumeng SU ; Yan ZHANG ; Chuanbo ZHAO ; Yonghao XU ; Wei ZHANG ; Jiping HUO ; Rong ZHOU ; Zhigang ZHAO
Herald of Medicine 2025;44(8):1257-1265
In this study,the similarities and differences of plasma collection and quality control in China and abroad were analyzed by comparing the related regulations,standards,guidelines and literatures.Rational and constructive suggestions were proposed,aiming to optimize domestic plasma management and promote the improvement of plasma-related standards.There was little difference on facilities and safety control process of plasma between China and the developed countries(United States,EU and Japan),However,significant differences existed on plasma station setting,donor screening standards,collection interval,volume limits,plasma testing modes and tests,plasma quarantine standard and utilization of recovered plasma.The United States sets the industry benchmark and is worthy of reference for our country both in plasma collection and quality control.
5.Research and Deveplopment Landscape and Industry Trends of Blood Product Enterprises in China and Abroad
Yanan XU ; Jiping HUO ; Qiang WU ; Ding YU ; Hong LIANG ; Rui FU ; Wenli MA ; Wei ZHANG ; Zhigang ZHAO
Herald of Medicine 2025;44(8):1272-1280
The blood products industry,both domestically and internationally,exhibits distinct features in product research,development,and technological innovation.International companies possess extensive expertise in developing immunoglobulins,coagulation factors,and recombinant plasma protein products,demonstrating continuous advancements-particularly in specific immunoglobulin development,long-acting formulation optimization,and manufacturing process improvements.In recent years,Chinese enterprises have also achieved notable progress in related fields,especially in immunoglobulin process refinement and the development of novel recombinant coagulation factor products.However,there remains significant scope for improvement in areas such as the application of recombinant protein technologies,efficient utilization of plasma resources,and the adoption of advanced manufacturing techniques.Additional challenges include the accumulation of patented technologies,the supply of critical raw materials,and access to comprehensive epidemiological data.Driven by ongoing advances in gene recombination technologies,innovations in drug delivery systems,digital transformation,and the rise of personalized medicine,the blood products industry is poised for broader development prospects.To foster sustained and stable domestic industry growth and enhance global competitiveness,Chinese blood product enterprises should intensify their technological accumulation,upgrade manufacturing processes,and optimize plasma resource utilization.
6.Education and certification model for radiation dosimetrists in the United States: Implications and reference for China
Wenjie WU ; Junliang XU ; Guoping SHAN ; Binbing WANG ; Feng LU ; Xue BAI ; Xiaolong CHENG ; Dannong RUAN ; Jiping LIU
Chinese Journal of Radiological Medicine and Protection 2025;45(1):69-73
Given the escalating number of cancer patients and the consequent rise in demand for radiation therapy in China, there is an urgent need to establish and improve a talent cultivation system for radiation dosimetrists. The United States, with an early-established cultivation system for radiation dosimetrists, boasts relatively mature and comprehensive systems of academic education and qualification certification. This study summarized and analyzed the educational and certification patterns for radiation dosimetrists in the United States based on public data from relevant institutions, related literature, and interviews with American radiation dosimetrists. Meanwhile, this study delved into and assessed the shortcomings in China′s radiation dosimetry education, examination, certification, and career advancement pathways. Furthermore, this study offered suggestions and recommendations for constructing a novel pattern tailored to the cultivation of radiation dosimetrists in China, in order to facilitate the high-quality development of the medical dosimetry discipline.
7.Similarities and Differences of Source Plasma Collection and Quality Control In China and Abroad
Demei DONG ; Yang GAO ; Yumeng SU ; Yan ZHANG ; Chuanbo ZHAO ; Yonghao XU ; Wei ZHANG ; Jiping HUO ; Rong ZHOU ; Zhigang ZHAO
Herald of Medicine 2025;44(8):1257-1265
In this study,the similarities and differences of plasma collection and quality control in China and abroad were analyzed by comparing the related regulations,standards,guidelines and literatures.Rational and constructive suggestions were proposed,aiming to optimize domestic plasma management and promote the improvement of plasma-related standards.There was little difference on facilities and safety control process of plasma between China and the developed countries(United States,EU and Japan),However,significant differences existed on plasma station setting,donor screening standards,collection interval,volume limits,plasma testing modes and tests,plasma quarantine standard and utilization of recovered plasma.The United States sets the industry benchmark and is worthy of reference for our country both in plasma collection and quality control.
8.Research and Deveplopment Landscape and Industry Trends of Blood Product Enterprises in China and Abroad
Yanan XU ; Jiping HUO ; Qiang WU ; Ding YU ; Hong LIANG ; Rui FU ; Wenli MA ; Wei ZHANG ; Zhigang ZHAO
Herald of Medicine 2025;44(8):1272-1280
The blood products industry,both domestically and internationally,exhibits distinct features in product research,development,and technological innovation.International companies possess extensive expertise in developing immunoglobulins,coagulation factors,and recombinant plasma protein products,demonstrating continuous advancements-particularly in specific immunoglobulin development,long-acting formulation optimization,and manufacturing process improvements.In recent years,Chinese enterprises have also achieved notable progress in related fields,especially in immunoglobulin process refinement and the development of novel recombinant coagulation factor products.However,there remains significant scope for improvement in areas such as the application of recombinant protein technologies,efficient utilization of plasma resources,and the adoption of advanced manufacturing techniques.Additional challenges include the accumulation of patented technologies,the supply of critical raw materials,and access to comprehensive epidemiological data.Driven by ongoing advances in gene recombination technologies,innovations in drug delivery systems,digital transformation,and the rise of personalized medicine,the blood products industry is poised for broader development prospects.To foster sustained and stable domestic industry growth and enhance global competitiveness,Chinese blood product enterprises should intensify their technological accumulation,upgrade manufacturing processes,and optimize plasma resource utilization.
9.Current status of self-management in patients with epilepsy and related influencing factors
Journal of Apoplexy and Nervous Diseases 2024;41(6):521-524
Objective To investigate the current status of self-management in adult patients with epilepsy and re-lated influencing factors.Methods Epilepsy Self-Management Scale(ESMS)was used to evaluate the self-management abilities of 180 patients with epilepsy in a district of Shanghai,China,and the impact of related factors on the self-management abilities of patients was analyzed,including demographic factors(sex,age,marital status,and educational level,etc.)and clinical factors(age of onset,course of disease,seizure frequency,and types of medication,etc.).Results The total score of self-management was(102.62±6.11)points for the patients with epilepsy.There was a sig-nificant difference in self-management score between the patients with different occupations(F=2.950,P<0.05)and be-tween the patients with different family incomes(F=7.298,P<0.05).The patients who missed fewer doses of antiepilep-tic drugs had a higher self-management score(F=35.948,P<0.05),and there was a significant difference in self-management score between the patients with different follow-up frequencies(F=15.619,P<0.05).Medication manage-ment showed the strongest correlation with safety management(r=0.435,P<0.05),while safety management showed the lowest correlation with seizure management score(r=-0.152,P<0.05).The multiple linear regression analysis showed that medication compliance and follow-up frequency in specialized care were influencing factors for total self-management score.Conclusion The patients with epilepsy have poor self-management abilities,and improving employment rate,in-creasing family income,enhancing medication compliance,and increasing follow-up frequency in specialized care have a certain clinical significance in improving the self-management abilities of patients.
10.Non-target metabolomic analysis of buccal pouch squamous cell carcinoma in Chinese hamsters
Ruihu ZHANG ; Yuan WANG ; Guoqiang XU ; Jiping GAO ; Guohua SONG ; Zhaoyang CHEN ; Rui-Jing XUAN
Journal of Practical Stomatology 2024;40(5):608-613
Objective:To explore the metabolic basis and related molecular mechanism of oral squamous cell carcinoma(OSCC)path-ogenesis.Methods:20 Chinese hamsters were divided into 2 groups(n=10).OSCC models were induced by dimethylbenzanthracene(DMBA)in 10 of the animals and the other 10 were used as the controls.LC-MS chromatography-mass spectrometry was used to iden-tify the metabolites in the buccal pouch,and multidimensional statistical analysis of the metabolites was performed with the orthogonal partial least squares discriminant analysis model.Variable Importance for the Projection(VIP)>1 and P<0.05 were used as the criteria to screen the differential metabolites between the 2 groups.KEGG pathway annotation and enrichment analysis for the metabolites were performed to screen the significantly differential pathways.Results:The hamster cheek pouches painted with 0.5%DMBA for 18 weeks were diffused with leukoplakia and loaded obvious papillary protrusions,which were diagnosed as OSCC by pathological examination.Lipids and lipid-like molecules were the main differential metabolites.Reprogramming of unsaturated fatty acid biosynthesis,cholesterol accumulation,enhanced catabolism of tryptophan,up-regulation of aspartate,increased synthesis of pyrimidine and purine,etc.were important metabolic features in the occurrence and development of OSCC.Conclusion:Molecular intervention targeting the related met-abolic pathways is expected to inhibit OSCC pathogenesis and progression.

Result Analysis
Print
Save
E-mail